QMS Medical Allied Services Announces Q3 FY26 Unaudited Financial Results and Audit Findings
QMS Medical Allied Services Limited has announced its unaudited financial results for the third quarter of the fiscal year ending June 30, 2026. The company released both standalone and consolidated results, along with supporting reports from independent auditors.The Board of Directors approved these results in a meeting held on August 14, 2026. The Company is engaged in Healthcare Equipments/Supplies and Services, operating as a single segment entity.
Unaudited Standalone Financial Results (Q3 FY26)
The unaudited standalone financial statements for the quarter ending June 30, 2026, have been prepared in accordance with Indian Accounting Standard 34 'Interim Financial Reporting'. The results reflect a Total Income of 525,881 Lakhs.Key figures from the standalone results are presented below:
| Particulars | Q3 Ended June 30, 2026 (Unaudited) | Q3 Ended March 31, 2026 (Audited) | Q3 Ended June 30, 2025 (Unaudited) | Year ended March 31, 2026 (Audited) |
|---|---|---|---|---|
| Revenue From Operations (Net of taxes) | 523,417 | 391,920 | 423,205 | 15,229.73 |
| Other Income | 2,464 | 7.36 | 1,520 | 3,608 |
| Total Income (net) | 525,881 | 392,656 | 424,725 | 15,265.81 |
| Purchase of Stock-in-Trade | 2,910.64 | 2,069.82 | 273,130 | 9,553.42 |
| Employee Benefits Expenses | 1,056.05 | 51,637 | 26,735 | 129,193 |
| Finance Cost | 20,482 | 2,712 | 17,727 | 80,066 |
| Depreciation and Amortisation Expenses | 13,053 | 12,155 | 83.15 | 41,162 |
| Other Expenses | 93,050 | 767.08 | 78,932 | 303,341 |
| Total Expenses | 4,869.02 | 3,840.40 | 3,850.02 | 1,433,465 |
| Profit before tax | 389.79 | 86.16 | 388.23 | 93,117 |
| Total Tax Expense | 12,241 | 2,335 | 11,998 | 272.60 |
| Profit for the period from continuing operations | 267.38 | 6,281 | 26,825 | 65,857 |
| Total comprehensive income for the period/year | 266.67 | 56.10 | 261.54 | 63,172 |
Unaudited Consolidated Financial Results (Q3 FY26)
The unaudited consolidated financial results are derived from the Parent and its subsidiary, Saarathi Healthcare Private Limited. The total income for the Group for the quarter ending June 30, 2026, stood at 572,844 Lakhs. These results were prepared in compliance with Ind AS 34.The consolidated financial results include details on equity share capital and earnings per share (EPS). The reported figures are as follows:
| Particulars | Q3 Ended June 30, 2026 (Unaudited) | Q3 Ended March 31, 2026 (Audited) | Q3 Ended June 30, 2025 (Unaudited) | Year ended March 31, 2026 (Audited) |
|---|---|---|---|---|
| Revenue From Operations (Net of taxes) | 5,686.66 | 444,238 | 464,950 | 1,728,765 |
| Other Income | 217 | 3,194 | 105.93 | - |
| Total Income (net) | 572,844 | 446,455 | 468,145 | 1,739,357 |
| Purchase of Stock-in-Trade | 300,598 | 209,854 | 278,251 | 10,014.08 |
| Employee Benefits Expenses | 111,690 | - | 2,164 | 1,476.99 |
| Finance Cost | 17,115 | 207.81 | 143.61 | 668.52 |
| Depreciation and Amortisation Expenses | 146.68 | 130.14 | 9,317 | 6,113 |
| Other Expenses | 1,121.36 | 1,053.13 | 1,081.14 | 3,885.86 |
| Total Expenses | 517,361 | 410,817 | 423,269 | 18,758.17 |
| Profit before tax | 55,483 | 26,639 | 44,875 | - |
Audit and Review Status
The standalone unaudited financial results were subjected to a Limited Review by statutory auditors, who issued an unmodified report. The review concluded that nothing came to their attention that suggested the statements contained any material misstatement or failed to disclose required information according to applicable accounting principles.Similarly, the consolidated unaudited financial results were reviewed by independent Chartered Accountants. This review also resulted in a conclusion stating that nothing had come to their attention causing belief that the accompanying statement contained any material misstatement.
QMSMEDI Stock Price Movement
Shares of QMS Medical Allied Services Limited edged higher to settle at ₹131.92, gaining 2.45% in trading today. The equity traded within an intraday range between a low of ₹126.00 and a high of ₹135.00, with a volume of 46,602 shares recorded.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: